drugset
drugset / Trial / NCT00168480

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

NCT00168480 ↗

Phase 4 Completed 424 enrolled Allergan
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a three year open-label study in subjects with axillary hyperhidrosis.

Timeline

Start
2003-11
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu —

Indications

No indication recorded.